Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma

Robert I. Griffiths, Michelle L. Gleeson, Joseph Mikhael, Martin H. Dreyling, Mark D. Danese

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint Dive into the research topics of 'Comparative effectiveness and cost of adding rituximab to first-line chemotherapy for elderly patients diagnosed with diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences